Lee Swanson Research Update

Cognizin® Citicoline Shows Attention-Boosting Potential

June 2011

A daily 250 mg dose of Cognizin® Citicoline may be effective for improving attention, according to new findings from the University of Utah Brain Institute.

The findings, presented at the 66th Annual Meeting of the Society of Biological Psychiatry in San Francisco, showed that a dose of 250 mg of the ingredient was just as effective as 500 mg for boosting the attentional function of healthy middle-aged women.

"Citicoline has been shown to have a variety of cognitive-enhancing and neuroregenerative properties in pre-clinical and clinical studies," said Deborah Yugelun-Todd, Ph.D., director of the Cognitive Neuroimaging Laboratory at The Brain Institute at the University of Utah.

"Our findings suggest that citicoline may mitigate the cognitive decline associated with normal aging and may ameliorate attentional deficits associated with psychiatric disorders," she added.

Sixty healthy women were randomized to one of three groups: The first group received a placebo, while the second and third groups received a daily dose of 250 mg or 500 mg of Cognizin Citicoline, respectively, for 28 days.

Using the Continuous Performance Test II (CPT-II), the researchers found that both supplement groups committed fewer errors, particularly those associated with non-target stimuli, said the researchers, thereby indicating an improvement in attention.

Presented at the Annual Meeting of the Society of Biological Psychiatry

New to Natural Health?
Tools
Customer Service